Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pegylated interferon alfa-CCR5 antagonist combination HIV therapy

Pegylated interferon alfa-CCR5 antagonist combination HIV therapy

US Patent 6635646 · Granted Oct 21, 2003

Estimated economic value: $83,541,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Piperazine derivatives useful as CCR5 antagonists2012
Piperazine derivatives useful as CCR5 antagonists2008
Pegylated interferon alfa-CCR5 antagonist combination HIV therapy2007
Piperazine derivatives useful as CCR5 antagonists2004
Piperidine derivatives useful as CCR5 antagonists2003
Piperidine derivatives useful as CCR5 antagonists2002